Patients with recurrent GC had higher concentrations of CXCL1, CXCL2, CXCL4, CXCL5, CXCL7, CXCL8, CXCL9, CXCL10, CXCL12, CXCL13, and CXCL14 in tumor drainage blood and peripheral blood compared to relapse-free patients. This evidence concerns the gene CXCL8 and gastric cancer.